✦ LIBER ✦

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

✍ Scribed by McInnes, Iain B; Kavanaugh, Arthur; Gottlieb, Alice B; Puig, Lluís; Rahman, Proton; Ritchlin, Christopher; Brodmerkel, Carrie; Li, Shu; Wang, Yuhua; Mendelsohn, Alan M; Doyle, Mittie K

Book ID: 120984213
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 355 KB
Volume: 382
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(13)60594-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ustekinumab in patients with active psor

Ustekinumab in patients with active psoriatic arthritis: Results of the phase III, multicenter, double-blind, placebo-controlled PSUMMIT I study

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Ustekinumab, an anti-IL-12/23 p40 monocl

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials

✍ Kavanaugh, Arthur (author);Ritchlin, Christopher (author);Rahman, Proton (author 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 984 KB

Ustekinumab, an anti-IL-12/23 p40 monocl

✍ Kavanaugh, Arthur (author);Ritchlin, Christopher (author);Rahman, Proton (author 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 984 KB

Safety and efficacy of golimumab in Chin

Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial

✍ Bao, C.; Huang, F.; Khan, M. A.; Fei, K.; Wu, Z.; Han, C.; Hsia, E. C. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 463 KB

Ustekinumab Improves Arthritis-Related A

Ustekinumab Improves Arthritis-Related And Skin-Related Quality Of Life In Patients With Active Psoriatic Arthritis: Patient Reported Outcomes From Randomized And Double Blinded Phase Iii Psummit I Trial

✍ Kavanaugh, A.; McInnes, I.; Gottlieb, A.; Puig, L.; Rahman, P.; Ritchlin, C.; Li 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Efficacy and safety of leflunomide compa

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

✍ Josef S Smolen; Joachim R Kalden; David L Scott; Blaz Rozman; Tore K Kvien; Arvi 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 111 KB